Epharmix works with leading physicians and independent researchers to generate clinical outcomes and publishes evidence for Epharmix technology. Results of Epharmix interventions have achieved ten peer-reviewed journal publications and over two dozen conference acceptances to-date.
Epharmix Research Center
Chief Medical Officer
From Phase II to Phase IV research, every Epharmix intervention must meet several critera. Fewer than 20% of intervention proposals make it past these phases.
The Epharmix Research Center is open to opportunities to inform people of our best practices.
Learn how providers in a resident clinic setting at a top academic institution reduced hospitalization risk with Epharmix.
See how care management at a large health system used Epharmix to quickly get patients with diabetes to control.
Patients in community and rural health system settings maintain high annual engagement on Epharmix.